相关实验视频
Updated: Jan 18, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.3K
冠状动脉支架后的蛋白胺硫酸的有效性和安全性
William Nicholson1, Khaled I Alnahhal2, John Han3
1Department of Surgery, MetroHealth System, Cleveland, OH, USA.
概括
胺硫酸盐有效地减少了跨动脉再血管化 (TCAR) 患者的出血并发症,而不会增加血栓形成的风险. 它的好处对于女性和接受ACE抑制剂的患者来说尤其重要,无论 Carotid Artery Stenting (CAS) 方法如何.
科学领域:
- 血管外科 血管外科
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺硫酸盐用于减轻心动脉支架 (CAS) 后出血风险.
- 在CAS之后,其在个性化患者护理中的有效性需要进一步调查.
- 确定影响蛋白胺硫酸盐益处的患者特定因素至关重要.
研究的目的:
- 为了确定与增强益处相关的因素,从胺硫酸盐的管理后CAS.
- 在不同的CAS程序中评估胺硫酸盐对出血并发症和不良血栓事件的影响.
主要方法:
- 血管质量倡议 (VQI) 2016-2022年数据的回顾性分析.
- 通过骨转移的CAS (TF-CAS) 和穿动脉再血管化 (TCAR) 患者队列的比较.
- 多变量分析和倾向得分匹配,以评估含有和不含胺硫酸盐的结果.
主要成果:
- 在TCAR和TF-CAS组中,原氨酸硫酸显著减少了女性患者和服用ACE抑制剂的患者的出血.
- 在TF-CAS中,蛋白胺硫酸盐与较低的全因死亡率 (7.9%与11.5%) 相关联,而不会增加肌心梗塞 (MI) 或中风/过时性缺血性发作 (TIA) 发生率.
- 与没有服用胺硫酸盐的TCAR患者相比,接受胺硫酸盐的TCAR患者的死亡率,心脏病发作和中风/TIA的发作率与没有接受胺硫酸盐的TCAR患者相似.
结论:
- 胺硫酸盐有效地减少TCAR患者的出血并发症,而不会增加血栓事件.
- 蛋白胺硫酸盐的益处在女性和接受ACE抑制剂的患者中明显,无论CAS方法如何.
- 虽然TF-CAS中胺硫酸盐的使用与降低死亡率有关,但其降低出血的益处并未普遍观察到,这表明选择性应用可能是合理的,特别是在女性和ACE抑制剂使用者身上.
相关概念视频
01:19Depolarizing Blockers: Pharmocokinetics
567
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
567
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
679
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
679
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:26Cardiac Catheterization IV: Nursing Management
661
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
661
01:21Skeletal Muscle Relaxants: Adverse Effects
776
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
776